- Potential benefitFacilitates diplomatic engagement and deeper institutional partnerships with ASEAN, CERN, and the Pacific Islands Forum.
- Potential benefitAuthorizes legal privileges and immunities for organization staff and premises, simplifying their U.S. operations.
- WorkersSupports scientific collaboration with CERN by easing administrative and legal barriers for research cooperation.
PARTNER with ASEAN, CERN, and PIF Act
Placed on Senate Legislative Calendar under General Orders. Calendar No. 95.
The bill authorizes the President to extend the privileges, immunities, and other provisions of the International Organizations Immunities Act to the Association of Southeast Asian Nations (ASEAN), the European Organization for Nuclear Research (CERN), and the Pacific Islands Forum (PIF). Each extension would be made “under such terms and conditions as the President shall determine,” and would treat these bodies like other public international organizations with which the United States participates.
Liberals emphasize diplomatic, scientific, and climate cooperation benefits
Relative to its intended legislative type, this bill plainly and narrowly accomplishes a substantive legal change by amending the International Organizations Immunities Act to authorize the President to extend statutory immunities to ASEAN, CERN, and PIF.
The bill authorizes the President to extend the privileges, immunities, and other provisions of the International Organizations Immunities Act to the Association of Southeast Asian Nations (ASEAN), the European Organization for Nuclear Research (CERN), and the Pacific Islands Forum (PIF).
Each extension would be made “under such terms and conditions as the President shall determine,” and would treat these bodies like other public international organizations with which the United States participates.
The measure is procedural and applies the IOIA framework to three named organizations to facilitate diplomatic, legal, and operational relations.
Technical statutory update with low fiscal impact and low controversy, historically the type of measure that often becomes law.
Relative to its intended legislative type, this bill plainly and narrowly accomplishes a substantive legal change by amending the International Organizations Immunities Act to authorize the President to extend statutory immunities to ASEAN, CERN, and PIF. It integrates cleanly into the existing statutory framework but relies heavily on broad executive discretion without procedural constraints, fiscal acknowledgment, or accountability measures.
Liberals emphasize diplomatic, scientific, and climate cooperation benefits
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenGrants immunities that may limit U.S. courts' jurisdiction over civil claims against organization personnel.
- Federal agenciesMay reduce federal and state tax revenue through exemptions for organization property and staff.
- Potential burdenCould constrain law enforcement actions against individuals or premises covered by extended immunities.
Why the argument around this bill splits.
Liberals emphasize diplomatic, scientific, and climate cooperation benefits
Likely broadly supportive.
The bill is seen as enabling deeper multilateral engagement, science diplomacy, and regional cooperation on issues like climate and development.
It is viewed as a low-cost, pragmatic step to strengthen partnerships and U.S. presence in key forums.
Generally favorable but cautious.
Seen as a routine diplomatic/legal step that simplifies relations, provided adequate oversight and clear limits on immunities.
Support would depend on transparency, reciprocal treatment, and minimal fiscal impact.
Likely cautious to skeptical.
While acknowledging diplomatic or scientific advantages, there is concern about extending legal immunities and granting broad executive authority without tighter congressional control.
Some may view it as unnecessary expansion of privileges to foreign bodies.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technical statutory update with low fiscal impact and low controversy, historically the type of measure that often becomes law.
- Potential legal or civil‑litigation objections to immunities
- Any congressional holds unrelated to substance
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberals emphasize diplomatic, scientific, and climate cooperation benefits
Technical statutory update with low fiscal impact and low controversy, historically the type of measure that often becomes law.
Relative to its intended legislative type, this bill plainly and narrowly accomplishes a substantive legal change by amending the International Organizations Immunities Act to authorize the President to extend statutory…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.